Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 62.6% in First Three Quarters of 2022

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 197.9 million yuan in the first three quarters of 2022, down 62.6% year-on-year.

Meanwhile, the company posted 10 billion yuan in revenue, up 2.6% year-on-year.

At the end of the reporting period, it had 13 billion yuan in total assets and 8.4 billion yuan in total liabilities, with a liability-to-asset ratio of 64.4%.